Anúncio
Anúncio

WVE

WVE logo

Wave Life Sciences Ltd. Ordinary Shares

13.84
USD
Patrocinado
-0.99
-6.68%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

13.95

+0.11
+0.77%

Relatórios de Lucros WVE

Rácio de surpresa positiva

WVE separação 9 de 40 últimas estimativas.

23%

Próximo Relatório

Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$17.33M
/
-$0.26
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+127.81%
/
-18.75%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-79.31%
/
-252.94%

Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue

On 10 de nov. de 2025, WVE reported earnings of -0.32 USD per share (EPS) for Q3 25, missing the estimate of -0.30 USD, resulting in a -6.21% surprise. Revenue reached 7.61 milhão, compared to an expected 11.24 milhão, with a -32.32% difference. The market reacted with a -10.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.26 USD, with revenue projected to reach 17.33 milhão USD, implying an diminuir of -18.75% EPS, and aumentar of 127.81% in Revenue from the last quarter.
FAQ
For Q3 2025, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.32, missing estimates by -6.21%, and revenue of $7.61M, -32.32% below expectations.
The stock price moved down -10.31%, changed from $7.86 before the earnings release to $7.05 the day after.
The next earning report is scheduled for 02 de mar. de 2026.
Based on 17 analistas, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.26 and revenue of $17.33M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio